Invention Grant
- Patent Title: Aminopyrazine diol compounds as PI3K-γ inhibitors
-
Application No.: US16295705Application Date: 2019-03-07
-
Publication No.: US10669262B2Publication Date: 2020-06-02
- Inventor: Stacey Shepard , Andrew P. Combs , Nikoo Falahatpisheh , Lixin Shao
- Applicant: Incyte Corporation
- Applicant Address: US DE Wilmington
- Assignee: Incyte Corporation
- Current Assignee: Incyte Corporation
- Current Assignee Address: US DE Wilmington
- Agency: Fish & Richardson P.C.
- Main IPC: C07D213/40
- IPC: C07D213/40 ; C07D241/20 ; C07D403/04 ; C07D403/14 ; C07D403/08 ; C07D413/04 ; C07D417/04 ; C07D405/12 ; C07B59/00 ; A61P35/00 ; A61P9/00 ; A61P25/28 ; A61P37/02 ; C07D241/28
Abstract:
This application relates to compounds of Formula (I): or pharmaceutically acceptable salts thereof, which are inhibitors of PI3K-γ which are useful for the treatment of disorders such as autoimmune diseases, cancer, cardiovascular diseases, and neurodegenerative diseases.
Public/Granted literature
- US20190276435A1 AMINOPYRAZINE DIOL COMPOUNDS AS PI3K-y INHIBITORS Public/Granted day:2019-09-12
Information query
